Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2005 1
2009 2
2012 1
2014 2
2015 2
2016 2
2017 2
2018 4
2019 3
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Cicero AFG, Colletti A, Bellentani S. Cicero AFG, et al. Nutrients. 2018 Aug 23;10(9):1153. doi: 10.3390/nu10091153. Nutrients. 2018. PMID: 30142943 Free PMC article.
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with a doubled prevalence in diabetic and obese
Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltrat
Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
Peng KY, Watt MJ, Rensen S, Greve JW, Huynh K, Jayawardana KS, Meikle PJ, Meex RCR. Peng KY, et al. J Lipid Res. 2018 Oct;59(10):1977-1986. doi: 10.1194/jlr.M085613. Epub 2018 Jul 24. J Lipid Res. 2018. PMID: 30042157 Free PMC article.
Nonalcoholic fatty liver disease (NAFLD) comprises fat-accumulating conditions within hepatocytes that can cause severe liver damage and metabolic comorbidities. Studies suggest that mitochondrial dysfunction contributes to its development and p …
Nonalcoholic fatty liver disease (NAFLD) comprises fat-accumulating conditions within hepatocytes that can cause …
Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial.
Parker HM, Cohn JS, O'Connor HT, Garg ML, Caterson ID, George J, Johnson NA. Parker HM, et al. Nutrients. 2019 Feb 23;11(2):475. doi: 10.3390/nu11020475. Nutrients. 2019. PMID: 30813440 Free PMC article. Clinical Trial.
Being overweight increases the risk of the development of metabolic conditions such as non-alcoholic fatty liver disease (NAFLD), which is itself an independent predictor of cardiovascular disease. Omega-3 polyunsaturated fatty
Being overweight increases the risk of the development of metabolic conditions such as non-alcoholic fatty liver
Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
Chen K , Chen X , Xue H , Zhang P , Fang W , Chen X , Ling W . Chen K , et al. Food Funct. 2019 Feb 20;10(2):814-823. doi: 10.1039/c8fo01236a. Food Funct. 2019. PMID: 30675881
Coenzyme Q10 (CoQ10) is a well-known anti-adipogenic factor that possesses the capability to regulate non-alcoholic fatty liver disease (NAFLD). However, the mechanism by which CoQ10 acts on NAFLD is sti
Coenzyme Q10 (CoQ10) is a well-known anti-adipogenic factor that possesses the capability to regulate non-alc
Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease.
Ajith TA. Ajith TA. Clin Exp Pharmacol Physiol. 2018 May;45(5):413-421. doi: 10.1111/1440-1681.12886. Epub 2017 Dec 19. Clin Exp Pharmacol Physiol. 2018. PMID: 29112771 Review.
The fatty infiltration is the primary cause of oxidative stress and inflammation in the non-alcoholic fatty liver disease (NAFLD), which can lead to the peroxidation of phospholipids, such as cardiolipin. ...The apoptosis along wit …
The fatty infiltration is the primary cause of oxidative stress and inflammation in the non-alcoholic fatty l
Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
Mantle D, Hargreaves I. Mantle D, et al. Antioxidants (Basel). 2019 Feb 16;8(2):44. doi: 10.3390/antiox8020044. Antioxidants (Basel). 2019. PMID: 30781472 Free PMC article. Review.
In this article, we review the potential role of supplementation with coenzyme Q10 (CoQ10) for the prevention or management of these disorders. ...Similarly, CoQ10 supplementation improves glycaemic control and vascular dysfunction in type II diabetes, …
In this article, we review the potential role of supplementation with coenzyme Q10 (CoQ10) for the prevention or manage …
Mtrr hypomorphic mutation alters liver morphology, metabolism and fuel storage in mice.
Sowton AP, Padmanabhan N, Tunster SJ, McNally BD, Murgia A, Yusuf A, Griffin JL, Murray AJ, Watson ED. Sowton AP, et al. Mol Genet Metab Rep. 2020 Mar 24;23:100580. doi: 10.1016/j.ymgmr.2020.100580. eCollection 2020 Jun. Mol Genet Metab Rep. 2020. PMID: 32257815 Free PMC article.
Nonalcoholic fatty liver disease (NAFLD) is associated with dietary folate deficiency and mutations in genes required for one-carbon metabolism. ...Overall, we demonstrated that adult Mtrr (gt/gt) female mice showed abnormal liver morphology tha …
Nonalcoholic fatty liver disease (NAFLD) is associated with dietary folate deficiency and mutations in genes req …
The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression.
Botham KM, Napolitano M, Bravo E. Botham KM, et al. Nutrients. 2015 Dec 1;7(12):9834-46. doi: 10.3390/nu7125501. Nutrients. 2015. PMID: 26633474 Free PMC article. Review.
Although non-alcoholic fatty liver disease (NAFLD), characterised by the accumulation of triacylglycerol in the liver, is the most common liver disorder, the causes of its development and progression to the more serious n
Although non-alcoholic fatty liver disease (NAFLD), characterised by the accumulation of triacylgl …
Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients.
Curcio A, Romano A, Cuozzo S, Nicola AD, Grassi O, Schiaroli D, Nocera GF, Pironti M. Curcio A, et al. Medicina (Kaunas). 2020 Oct 17;56(10):544. doi: 10.3390/medicina56100544. Medicina (Kaunas). 2020. PMID: 33080906 Free PMC article.
Background and Objectives: Non-Alcoholic Fatty Liver Disease (NAFLD) is an emerging cause of hepatopathy that is showing an increasing trend and where the recommendations of lifestyle modification are often not sufficient. The aim of this …
Background and Objectives: Non-Alcoholic Fatty Liver Disease (NAFLD) is an emerging cause of hepat …
Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA. Farsi F, et al. J Am Coll Nutr. 2016 May-Jun;35(4):346-53. doi: 10.1080/07315724.2015.1021057. Epub 2015 Jul 9. J Am Coll Nutr. 2016. PMID: 26156412 Clinical Trial.
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disorder related to inflammation. Coenzyme Q10 (CoQ10) is a natural compound that has recently been considered as an anti-inflammatory factor. ...
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disorder related to inflammation. …
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page